Ndi Medical, LLC
NDI (Neuro Device Innovations) is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies. Founded in 2002 and headquartered in Cleveland, Ohio, NDI develops opportunities in the neurotechnology market, which exceeds $6 billion annually. The company has a proven track record of moving technologies from innovation to commercialization, including the sale of a urinary incontinence product to Medtronic for $42 million. NDI invests in and develops neurodevice technologies that address unmet clinical needs, with a focus on markets such as pain, Parkinson’s disease, depression, epilepsy, obesity, and stroke. It has established collaborations with institutions like Ohio Neurostimulation and Neuromodulation Partnership, Cleveland FES Center, and Duke University.
Industries
Nr. of Employees
small (1-50)
Ndi Medical, LLC
22901 Millcreek Blvd., Suite 110, Cleveland, Ohio 44122
Products
Deep brain stimulation optimization technology
Technology intended to improve the effectiveness of deep brain stimulation therapy across multiple clinical indications such as Parkinson’s disease.
Peripheral nerve stimulation system for pain management
A peripheral nerve stimulation system designed to treat multiple pain indications and advanced through grant-funded clinical programs.
Intraoperative nerve stimulation devices and surgical instruments
Devices and instruments intended for intraoperative nerve stimulation to protect and repair nerves during surgery.
Urinary incontinence neurostimulation device (historical exit)
An implantable neurostimulation device previously developed and sold to a strategic acquirer as an example of a completed exit.
Deep brain stimulation optimization technology
Technology intended to improve the effectiveness of deep brain stimulation therapy across multiple clinical indications such as Parkinson’s disease.
Peripheral nerve stimulation system for pain management
A peripheral nerve stimulation system designed to treat multiple pain indications and advanced through grant-funded clinical programs.
Intraoperative nerve stimulation devices and surgical instruments
Devices and instruments intended for intraoperative nerve stimulation to protect and repair nerves during surgery.
Urinary incontinence neurostimulation device (historical exit)
An implantable neurostimulation device previously developed and sold to a strategic acquirer as an example of a completed exit.
Services
Providing seed and growth capital for neurodevice projects and portfolio companies through a dedicated healthcare fund.
Shared-service incubation including engineering, regulatory, IP and business development to accelerate product development and company formation.
Regulatory strategy, agency interfacing and implementation of quality assurance and conformity assessment activities to support medical device approvals and commercialization.
Providing seed and growth capital for neurodevice projects and portfolio companies through a dedicated healthcare fund.
Shared-service incubation including engineering, regulatory, IP and business development to accelerate product development and company formation.
Regulatory strategy, agency interfacing and implementation of quality assurance and conformity assessment activities to support medical device approvals and commercialization.
Expertise Areas
- Neurodevice commercialization
- Venture funding and fund management
- Neuromodulation device engineering
- Clinical trial and grant-funded research management
Key Technologies
- Implantable pulse generators
- External pulse generators
- Leads and electrodes
- Surgical deployment tools
News & Updates
Case Western Reserve University, in collaboration with NDI Medical LLC, SPR Therapeutics, and Valtronic, received a $3 million grant from the Ohio Third Frontier Commission to develop a neurostimulation technology platform for treating pain and muscle paralysis.
NDI Medical LLC launched its portfolio company, Deep Brain Innovations, LLC (DBI), to commercialize technology designed to optimize deep brain stimulation therapy for Parkinson’s disease, expanding a market generating over $275 million annually.
NDI Medical LLC raised $4 million to develop nerve-stimulating devices, including a $2 million grant from the Ohio Third Frontier program and $6 million from other investors.
NDI Medical sold a device to Medtronic Inc. for $42 million, plans to reinvest the proceeds into product development, and will remain in Cleveland.
NDI Medical launched the NDI Healthcare Fund with a $2 million grant from Ohio’s Third Frontier program, aiming to finance seed-stage neurodevice companies and technologies.
Checkpoint Surgical, a neurostimulation device company, completed a $1.7 million Series B investment led by NDI Healthcare Fund, aiming to expand sales and marketing.
Case Western Reserve University, in collaboration with NDI Medical LLC, SPR Therapeutics, and Valtronic, received a $3 million grant from the Ohio Third Frontier Commission to develop a neurostimulation technology platform for treating pain and muscle paralysis.
NDI Medical LLC launched its portfolio company, Deep Brain Innovations, LLC (DBI), to commercialize technology designed to optimize deep brain stimulation therapy for Parkinson’s disease, expanding a market generating over $275 million annually.
NDI Medical LLC raised $4 million to develop nerve-stimulating devices, including a $2 million grant from the Ohio Third Frontier program and $6 million from other investors.
NDI Medical sold a device to Medtronic Inc. for $42 million, plans to reinvest the proceeds into product development, and will remain in Cleveland.
NDI Medical launched the NDI Healthcare Fund with a $2 million grant from Ohio’s Third Frontier program, aiming to finance seed-stage neurodevice companies and technologies.
Checkpoint Surgical, a neurostimulation device company, completed a $1.7 million Series B investment led by NDI Healthcare Fund, aiming to expand sales and marketing.